Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives.

Heliyon · 2024 · PMC11470528 · PMID 39397977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Moreover, the levels of acetylcarnitine exhibited a decreasing trend as the HCC progressed from stage T1 to T4.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.